Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 925 blog entries.

October 2026

Aignostics Joins Techcyte Fusion® Partner Program to Bring PathoSearch to Fusion AP

2026-10-06T09:05:52+00:00

Techcyte, the developer of Fusion, the unified anatomic and clinical pathology AI platform, today announced that Aignostics has joined the Techcyte Fusion® Partner Program. The companies have integrated Aignostics’ PathoSearch application into Techcyte Fusion AP, allowing pathologists to search for morphologically similar cases from within the slide viewer, using the image itself rather than a written [...]

Aignostics Joins Techcyte Fusion® Partner Program to Bring PathoSearch to Fusion AP2026-10-06T09:05:52+00:00

Innovators at the Table: The Right Treatment for the Right Patient – Podcast

2026-10-01T08:24:33+00:00

By Abigail Diepeveen How do you answer one of the most consequential questions in cancer care: not just whether a patient has cancer, but which treatment will actually help them? For years, the answer was hidden in plain sight. In this episode of PathPulse, part of our Behind the Summit series spotlighting the sponsors [...]

Innovators at the Table: The Right Treatment for the Right Patient – Podcast2026-10-01T08:24:33+00:00

September 2026

Techcyte Receives 2026 Innovation Award from Sonora Quest Laboratories

2026-09-29T12:52:02+00:00

Techcyte, the leader in AI-powered digital microbiology, today announced that it has received the 2026 Innovation Award from Sonora Quest Laboratories during the organization’s Strategic Supplier Summit. Techcyte was one of approximately 30 suppliers selected from more than 1,000 Sonora Quest Laboratories suppliers to participate in the summit and one of five organizations recognized with a [...]

Techcyte Receives 2026 Innovation Award from Sonora Quest Laboratories2026-09-29T12:52:02+00:00

Foundation Models for Digital Pathology: How Waiv Is Changing Cancer Diagnostics

2026-09-29T12:38:55+00:00

In a wide-ranging conversation on the Base to Base Biotech podcast with host Jim Cornall, Waiv CEO and Co-Founder Meriem Sefta traced the company's journey from an internal Owkin project to an independent business, the opportunity in digital pathology and why foundation models could change how cancer diagnostics are developed and delivered. Author: Rachel MacMaster [...]

Foundation Models for Digital Pathology: How Waiv Is Changing Cancer Diagnostics2026-09-29T12:38:55+00:00

UK digital pathology provider Source BioScience selects Sectra to enable seamless pathology collaboration across the NHS

2026-10-05T13:15:24+00:00

International medical imaging IT and cybersecurity company Sectra has signed an agreement with Source BioScience UK Ltd in the UK to deliver its service for advanced share and collaborate workflows. As the first Sectra customer in this domain, Source BioScience will now be able to support NHS organisations that need to send pathology cases to external specialists. [...]

UK digital pathology provider Source BioScience selects Sectra to enable seamless pathology collaboration across the NHS2026-10-05T13:15:24+00:00

Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients

2026-09-28T13:36:51+00:00

Acquisition advances Leica Biosystems’ end-to-end anatomic pathology ecosystem, expanding integrated solutions that help laboratories move from sample to answer with speed and confidence for the clinicians and patients who depend on them Leica Biosystems, a Danaher company (the “Company”) and a global leader in digital and anatomic pathology solutions advancing precision cancer diagnostics, announced today [...]

Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients2026-09-28T13:36:51+00:00

Source BioScience Expands Access to Hereditary Cancer Testing to Support Informed Patient Care

2026-09-28T09:42:59+00:00

Source BioScience is highlighting its hereditary cancer testing service, designed to help individuals and healthcare professionals better understand inherited cancer risk and make more informed decisions around screening, lifestyle and ongoing care. Around 5–10% of cancers are associated with inherited genetic variants that can increase an individual’s risk of developing certain types of cancer. Identifying these [...]

Source BioScience Expands Access to Hereditary Cancer Testing to Support Informed Patient Care2026-09-28T09:42:59+00:00

Real-World Validation of PathProfiler as an Open-Source Tool for WSI Quality Control

2026-09-29T14:22:22+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  A new retrospective study investigated whether PathProfiler, an open-source AI tool, could catch quality issues in digital prostate needle biopsies. Across 226 whole slide images (WSIs) of prostate needle core biopsies, PathProfiler flagged suboptimal cases with high sensitivity and negative predictive value. According to the [...]

Real-World Validation of PathProfiler as an Open-Source Tool for WSI Quality Control2026-09-29T14:22:22+00:00

From digital transformation to AI readiness: University Medical Center Göttingen’s Journey in Digital Pathology

2026-09-29T18:10:53+00:00

Join Prof. Dr. med. Philipp Ströbel to learn how one of Germany’s pioneering academic pathology institutes teamed up with Philips transformed its pathology operations through digital pathology. The session covers UMG’s journey from early adoption to an optimized, fully digital workflow; lessons in workflow redesign and change management; and how digital pathology creates the foundation for [...]

From digital transformation to AI readiness: University Medical Center Göttingen’s Journey in Digital Pathology2026-09-29T18:10:53+00:00

Leica Biosystems Brings Tempus Pathology Products to Aperio AI Store, Accelerating AI-Powered Capabilities for Oncology Research

2026-09-24T15:27:38+00:00

Expansion of the Aperio AI Store gives researchers more ways to study cancer through AI-enabled tools within a connected digital pathology  ecosystem Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, announces the addition of two  Paige digital pathology AI-enabled products from Tempus to its growing Aperio AI [...]

Leica Biosystems Brings Tempus Pathology Products to Aperio AI Store, Accelerating AI-Powered Capabilities for Oncology Research2026-09-24T15:27:38+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top